Research output per year
Research output per year
Personal profile
Headline
ASSISTANT PROFESSOR | Urology
Fingerprint
Dive into the research topics where John Sfakianos is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A rare case of metachronous pituitary germinoma and testicular seminoma: The role of tumor markers in diagnosis and the influence of glucocorticoids on disease progression
Sheskier, R., Verma, P., Kirschenbaum, A., Orelowitz, B., Umphlett, M., Sharif, U., Sfakianos, J., Schlachter, L., Bederson, J. & Levine, A. C., Jun 2025, In: Journal of Clinical and Translational Endocrinology: Case Reports. 36, 100182.Research output: Contribution to journal › Article › peer-review
Open Access -
Association of Tumor-informed Circulating Tumor DNA Detectability Before and After Radical Cystectomy with Disease-free Survival in Patients with Bladder Cancer
Sfakianos, J. P., Basu, A., Laliotis, G., Cumarasamy, S., Rich, J. M., Kommalapati, A., Glover, M., Mahmood, T., Tillu, N., Hoimes, C. J., Selig, G., Kollipara, R., Stewart, T. F., Rivero-Hinojosa, S., Dutta, P., Calhoun, M., Sharma, S., Malhotra, M., ElNaggar, A. C. & Liu, M. C. & 7 others, , 1 Apr 2025, In: European urology oncology. 8, 2, p. 306-314 9 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Clinical Implications of Basic Research: Exploring the Transformative Potential of Spatial 'Omics in Uro-oncology
Figiel, S., Bates, A., Braun, D. A., Eapen, R., Eckstein, M., Manley, B. J., Milowsky, M. I., Mitchell, T. J., Bryant, R. J., Sfakianos, J. P. & Lamb, A. D., Jan 2025, In: European Urology. 87, 1, p. 8-14 7 p.Research output: Contribution to journal › Review article › peer-review
Open Access2 Scopus citations -
Contemporary outcomes for robotic radical cystectomy and intracorporeal neobladder urinary diversion
Rich, J. M., Tillu, N., Geduldig, J., Ben-David, R., Lavallee, E., Wang, Y. S. A., Attalla, K., Dey, L., Aron, M., Ballon, J., Cacciamani, G. E., Desai, M. M., Gill, I. S., Hosseini, A. A., Hosseini, A., Miranda, G., Rautiola, J., Skokic, V., Steineck, G. & Mehrazin, R. & 2 others, , 2025, (Accepted/In press) In: Urologic Oncology: Seminars and Original Investigations.Research output: Contribution to journal › Article › peer-review
-
Differential response of low- and high-grade intermediate-risk non-muscle-invasive bladder cancer to bacillus Calmette-Guérin and gemcitabine-docetaxel therapy
Eraky, A., Kolanukuduru, K. P., Hug, B., Ben-David, R., Attalla, K., Waingankar, N., Wiklund, P., Mehrazin, R. & Sfakianos, J. P., 2025, (Accepted/In press) In: Urologic Oncology: Seminars and Original Investigations.Research output: Contribution to journal › Article › peer-review
1 Scopus citations
Press/Media
-
Findings on Disease-Free Survival Discussed by Investigators at Icahn School of Medicine at Mount Sinai (Association of Tumor-informed Circulating Tumor Dna Detectability Before and After Radical Cystectomy With Disease-free Survival In ...)
Mehrazin,, R., Sfakianos, J. & Wiklund, P.
28/04/25
1 item of Media coverage
Press/Media
-
New Radical Cystectomy Findings from Mount Sinai Hospital Reported (The Prognostic Significance of Circulating Tumor Dna In Patients With Positive Lymph Node Disease After Robotic-assisted Radical Cystectomy: a Contemporary Analysis)
Mehrazin,, R., Sfakianos, J., Wiklund, P. & Attalla, K.
2/01/25
1 item of Media coverage
Press/Media
-
End-of-Quarter Synopsis Monthly : Tilray Brands (TLRY: $1.33) falls a second month, trailing 72% of stocks
Kaplan,, S. & Sfakianos, J.
31/12/24
1 item of Media coverage
Press/Media
-
Investigators from Icahn School of Medicine at Mount Sinai Target Squamous Cell Carcinoma (Squamous Cell Carcinoma of the Upper Urinary Tract: Clinical Characteristics, Treatment Patterns, and Survival Outcomes In the National Cancer Database)
Mehrazin,, R., Badani, K., Tomer, N. & Sfakianos, J.
19/12/24
1 item of Media coverage
Press/Media
-
Weekly: Tilray Brands (TLRY: $1.28) shares post worst week in three weeks; -6c [4.5%]
Kaplan,, S. & Sfakianos, J.
7/12/24
1 item of Media coverage
Press/Media